Table 1 (abstract P341). Characteristics of included articles
From: Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)
Study | Design | Primairy outcome | Patients (n) | Female (%) | Disease duration at study enrollment, months means (SD) | JIA subtypes (%) |
|---|---|---|---|---|---|---|
Malleson et al. 20041 | Cross-sectional | Prediction model, VAS pain | 301 | 77 | Median: 73,2 | Poly:31 Oligo: 56 Systemic:13 |
Taxter et al. 20152 | Retrospective, 2 years | Patient reported outcomes amongst JIA subtypes, NRS pain | 398 | 65 | 2,4 (NA) | Poly: 17 Oligo:37 Systemic: 8 Psoriatic: 7 ERA: 23 Undiff.: 8 |
Shiff et al. 20183 | Prospective, 5 years | Pain severity trajectories, VAS pain | 1062 | 63.8 | < 12 months | Poly: 24.5 Oligo: 40 Systemic: 6 Psoriatic: 5.7 ERA: 13.5 |
Arnstad et al. 20184 | Prospective, 8 years | Pain at onset related to longterm outcomes JIA, VAS pain. | 243 | 70 | At 8 year follow-up: median (IQR) 97(95-102) | Oligo: 49 |
Learoyd et al. 20195 | Retrospective, 1 year | Pain severity trajectories, VAS pain. | 97 | 57 | 6.78(5.17) | Oligio: 6.2 Poly: 55.7 Systemic: 5.2 ERA: 33.0 |